Article Text

PDF

CE-43 Factors associated with neuropsychiatric involvement in 1193 latin american patients with systemic lupus erythematosus
  1. Leonor A Barile-Fabris1,
  2. Daniel Wojdyla2,
  3. Luis J Catoggio2,
  4. Hugo R Scherbarth2,
  5. Verónica Saurit2,
  6. Eloisa Bonfa3,
  7. Lilian T Lavras Costallat3,
  8. Fernando Cavalcanti3,
  9. José F Molina4,
  10. Gil Reyes-Llerena5,
  11. Loreto Massardo6,
  12. Mary C Amigo1,
  13. Luis H Silveira1,
  14. José L Alfaro7,
  15. Rosa Chacón8,
  16. Graciela S Alarcón9 and
  17. Bernardo A Pons-Estel2
  1. 1GLADEL Mexico
  2. 2GLADEL Argentina
  3. 3GLADEL Brasil
  4. 4GLADEL Colombia
  5. 5GLADEL Cuba
  6. 6GLADEL Chile
  7. 7GLADEL Peru
  8. 8GLADEL Venezuela
  9. 9GLADEL USA (associated)

Abstract

Introduction Neuropsychiatric (NP) manifestations in SLE are a major cause of morbidity, mortality and long term consequences.

Factors related to their occurrence in patients with short disease duration, both early in the course of the disaease and during follow up have not been clearly established.

Purpose To identify disease and non-disease related factors associated with NP manifestations in early SLE.

Methods We included 1193 patients from the GLADEL inception cohort free of NP involvement at cohort entry. We examined the relationship between socio-demographic, clinical and laboratory data as well as disease activity and damage with NP involvement during follow-up. Data were recorded in ARTHROS database. We excluded all the secondary NP manifestations (metabolic, drug induced, infectious, etc). Statistical methods The time from cohort entry to first NP manifestation was examined using a Cox proportional hazard regression model. Patients without NP manifestations were censored at last study visit. Independent factors associated with NP involvement were identified using a multivariable Cox regression model. Variables included in the final model were selected using a backward selection algorithm with α-level to stay in the model set to 0.05. Results are summarised as hazard ratios with 95% confidence intervals.

Results During a median follow-up time of 52 months, 238 (20 %) patients had NP involvement. The cumulative incidence estimate of NP involvement at 1, 3 and 5 years was 8.3%, 17.8% and 24.7%, respectively. In the univariable analysis some variables like ethnic origin were found to be more frequent in mestizos as compared to patients in the other ethnic groups. Factors independently associated with NP manifestations during follow up are listed in Table 1.

Conclusions There are both disease and non-disease related factors that are clearly associated with NP manifestations. Patients of Mestizo background, those with myositis and those with hemolytic anaemia are at higher risk of developing NP.

Features Predictive of the Occurrence of NP Manifestations by Multivariable Cox regression model

View this table:

Abstract CE-43 Table 1 Multivariate Model for Neurological Manifestations During Follow-Up

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.